pubCovid_id;pubCovid_title;covid19_language;pubCovid_type;pubCovid_keyWords;pubCovid_pubMedID;pubCovid_pubDate;pubCovid_author;pubCovid_country;pubCovid_journalID;pubCovid_journal;pubCovid_pubDetails;pubCovid_category;pubCovid_doi;pubCovid_link 37;Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19?;English;View;COVID-19, SARS-CoV-2,Chloroquine, Drug repurposing, Teicoplanin;32179150;13/03/2020;Baron SA. et al.;France;138;Int J Antimicrob Agents. 2020;Int J Antimicrob Agents. 2020 Mar 13:105944.;Chloroquine/Remdesivir/Teicoplanin;10.1016/j.ijantimicag.2020.105944.;https://www.sciencedirect.com/science/article/pii/S0924857920300947?via%3Dihub 96;Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.;English;Review;COVID-19, 2019-nCoV, Acute respiratory disease, Asymptomatic carrier, Coronavirus, SARS-CoV-2, Wuhan pneumonia;32173241;04/03/2020;Lai CC. et al.;Taiwan;172;J Microbiol Immunol Infect.;J Microbiol Immunol Infect. 2020 Mar 4. pii: S1684-1182(20)30040-2.;Chloroquine/Remdesivir;10.1016/j.jmii.2020.02.012.;https://www.sciencedirect.com/science/article/pii/S1684118220300402?via%3Dihub 209;COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease.;English;Review;"2019-nCoV; COVID-19; Chinese Medicine; Guideline; Integrative Medicine; Review";32164424;13/03/2020;Chan KW. et al.;Hong Kong;27;Am J Chin Med.;Am J Chin Med. 2020 Mar 13:1-26.;Remdesivir/Lopinavir-Ritonavir;10.1142/S0192415X20500378. ;https://www.worldscientific.com/doi/abs/10.1142/S0192415X20500378 220;[Pharmacotherapeutics for the new coronavirus pneumonia].;English;Review;"Antibiotics; Glucocorticosteroid; New coronavirus pneumonia; Pharmacotherapeutics";32164081;30/03/2020;Du B. et al.;China;91;Zhonghua Jie He He Hu Xi Za Zhi.;"Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):173-176.";Remdesivir;10.3760/cma.j.issn.1001-0939.2020.0;http://rs.yiigle.com/CN112147202003/1184474.htm 319;Compounds with therapeutic potential against novel respiratory 2019 coronavirus.;English;Minireview;"SARS-CoV-2; antiviral agents; coronavirus";32152082;21/04/2020;Martinez MA. et al.;Spain;49;Antimicrob Agents Chemother.;Antimicrob Agents Chemother. 2020 Mar 9. pii: AAC.00399-20.;Remdesivir/Lopinavir-Ritonavir;10.1128/AAC.00399-20.;https://aac.asm.org/content/64/5/e00399-20 359;Discovering drugs to treat coronavirus disease 2019 (COVID-19).;English;Communication;COVID-19, SARS-CoV-2,Chloroquine;32147628;08/03/2020;Dong L et al.;China;78;Drug Discov Ther.;"Drug Discov Ther. 2020;14(1):58-60. ";Chloroquine/Remdesivir;10.5582/ddt.2020.01012.;https://www.jstage.jst.go.jp/article/ddt/14/1/14_2020.01012/_article 362;Arguments in favor of remdesivir for treating SARS-CoV-2 infections.;English;EDITORIAL;"Betacoronavirus; COVID-19; Coronavirus disease 2019; Remdesivir; SARS-CoV-2; Wuhan pneumonia";32147516;06/03/2020;Ko WC. et al.;Taiwan;138;Int J Antimicrob Agents.;Int J Antimicrob Agents. 2020 Mar 5:105933.;Remdesivir;10.1016/j.ijantimicag.2020.105933.;https://www.sciencedirect.com/science/article/pii/S0924857920300832?via%3Dihub 387;Remdesivir as a possible therapeutic option for the COVID-19.;English;Review;"COVID-19; Remdesivir";32145386;05/03/2020;Al-Tawfiq JA. et al.;Saudi Arabia/USA;212;Travel Med Infect Dis.;Travel Med Infect Dis. 2020 Mar 5:101615.;Remdesivir;10.1016/j.tmaid.2020.101615.;https://www.sciencedirect.com/science/article/pii/S1477893920300831?via%3Dihub 388;Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.;English;COMMENT;COVID-19, SARS-CoV-2,Chloroquine;32145363;04/03/2020;Colson P. et al.;France;138;Int J Antimicrob Agents.;Int J Antimicrob Agents. 2020 Mar 4:105932.;Chloroquine/Hhydroxychloroquine/Remdesivir;10.1016/j.ijantimicag.2020.105932.;https://www.sciencedirect.com/science/article/pii/S0924857920300820?via%3Dihub#! 449;The 2019 Novel Coronavirus Outbreak - A Global Threat.;English;EDITORIAL;"2019-nCoV; Coronavirus";32138488;14/01/2020;Khot WY. and Nadkar MY.;India;228;J Assoc Physicians India.;"J Assoc Physicians India. 2020 Mar;68(3):67-71.";Remdesivir/Lopinavir-Rritonavir/Lopinavir-Rritonavir and interferon-beta;10.3760/cma.j.issn.1001-0939.2020.03.004.;https://www.ijidonline.com/article/S1201-9712(20)30011-4/fulltext 508;Therapeutic options for the 2019 novel coronavirus (2019-nCoV).;English;COMMENT;"2019-nCoV; Coronavirus";32127666;10/02/2020;Li G. and De Clercq E.;China;229;Nat Rev Drug Discov.;"Nat Rev Drug Discov. 2020 Mar;19(3):149-150.";Chloroquine/Remdesivir ;10.1038/d41573-020-00016-0.;https://www.nature.com/articles/d41573-020-00016-0 567;Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.;English;Research Article;"COVID-19; Docking; Nucleotide inhibitors; RdRp; Sofosbuvir; Structural bioinformatics; Wuhan coronavirus";32119961;01/05/2020;Elfiky AA.;Saudi Arabia;222;Life Sci. 2020;"Life Sci. 2020 Feb 28;248:117477.";Remdesivir;10.1016/j.lfs.2020.117477.;https://www.sciencedirect.com/science/article/pii/S0024320520302253?via%3Dihub 737;The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.;English;Research Article;"Ebola virus (EBOV); Middle East respiratory syndrome coronavirus (MERS–CoV); RNA chain termination; RNA-dependent RNA polymerase (RdRp); SARS–CoV-2; antiviral drug; coronavirus; drug development; enzyme inhibitor; nucleoside/nucleotide analog; plus-stranded RNA virus; positive-sense RNA virus; remde";32094225;10/04/2020;Gordon CJ. et al.;Canada;219;J Biol Chem.;"J Biol Chem. 2020 Apr 10;295(15):4773-4779.";Remdesivir;10.1074/jbc.AC120.013056.;https://www.jbc.org/content/295/15/4773 796;Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.;English;Research Article;"2019-nCoV; COVID-19; China; Epidemic; Remdesivir; SARS-CoV-2";32081636;30/03/2020;Lai CC. et al.;Taiwan;138;Int J Antimicrob Agents. 2020;"Int J Antimicrob Agents. 2020 Mar;55(3):105924.";Remdesivir;10.1016/j.ijantimicag.2020.105924.;https://www.sciencedirect.com/science/article/pii/S0924857920300674?via%3Dihub 836;Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients.;English;Review;COVID-19;32317557;17/04/2020;Jacobs JP. et al.;USA;213;ASAIO J.;ASAIO J. 2020 Apr 17.;Hydroxychloroquine/Remdesivir/Tocilizumab /Sarilumab;10.1097/MAT.0000000000001185.;https://journals.lww.com/asaiojournal/Abstract/9000/Extracorporeal_Membrane_Oxygenation_in_the.98533.aspx 895;Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.;English;Research Article;"MERS-CoV; animal model; antiviral; remdesivir; therapy";32054787;24/03/2020;de Wit E. et al.;USA;221;Proc Natl Acad Sci U S A. 2020;Proc Natl Acad Sci U S A. 2020 Feb 13. pii: 201922083.;Remdesivir;10.1073/pnas.1922083117.;https://www.pnas.org/content/117/12/6771 999;[Potential antiviral therapeutics for 2019 Novel Coronavirus].;English;View;"2019 novel coronavirus; Antiviral therapy; Infection";32023685;05/02/2020;Li H. et al.;China;91;Zhonghua Jie He He Hu Xi Za Zhi.;"Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 5;43(0):E002.";Remdesivir/Lopinavir-Ritonavir;10.3760/cma.j.issn.1001-0939.2020.0002.;http://rs.yiigle.com/yufabiao/1179590.htm 1007;Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.;English;Review;"2019-nCoV; 3CLpro; RdRp; SARS; antiviral agents; coronavirus; spike proteins";32022370;02/03/2020;Morse JS. et al.;USA;220;Chembiochem. 2020;"Chembiochem. 2020 Mar 2;21(5):730-738.";Remdesivir;10.1002/cbic.202000047.;https://chemistry-europe.onlinelibrary.wiley.com/doi/full/10.1002/cbic.202000047 1012;Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.;English;COMMENT;COVID-19, SARS-CoV-2,Chloroquine;32020029;30/03/2020;Wang M. et al.;China;83;Cell Res.;"Cell Res. 2020 Mar;30(3):269-271.";Chloroquine/Remdesivir;10.1038/s41422-020-0282-0.;https://www.nature.com/articles/s41422-020-0282-0 1047;Drug treatment options for the 2019-new coronavirus (2019-nCoV).;English;Communication;"2019-nCoV; Coronaviruses; pneumonia";31996494;16/03/2020;Lu H. et al.;China;59;Biosci Trends.;"Biosci Trends. 2020 Mar 16;14(1):69-71.";Remdesivir/Lopinavir-Ritonavir/Umifenovir;10.5582/bst.2020.01020.;https://www.jstage.jst.go.jp/article/bst/14/1/14_2020.01020/_article 1459;A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19).;English;Review;COVID-19, SARS-CoV-2,Chloroquine, ace2, ards, lopinavir and ritonavir, mrna-1273 vaccine, pandemic, remdesivir (gs-5734),severe acute respiratory infection;32269893;06/04/2020;Kakodkar P et aL.;Ireland;147;Cureus;"Cureus. 2020 Apr 6;12(4):e7560";Chloroquine/Remdesivir;10.7759/cureus.7560.;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138423/ 1466;Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV.;English;Review;COVID-19, SARS-CoV-2,Chloroquine;32247050;01/04/2020;Xie M. and Chen Q.;China;89;Int J Infect Dis.;Int J Infect Dis. 2020 Apr 1. pii: S1201-9712(20)30204-6.;Chloroquine/Remdesivir;10.1016/j.ijid.2020.03.071;https://linkinghub.elsevier.com/retrieve/pii/S1201-9712(20)30204-6 1467;Potential therapeutic agents against COVID-19: What we know so far.;English;Review;COVID-19, SARS-CoV-2,Chloroquine;32243270;01/04/2020;Lu CC.;Taiwan;169;J Chin Med Assoc.;J Chin Med Assoc. 2020 Apr 1.;Chloroquine/Remdesivir/Lopinavir-Ritonavir;10.1097/JCMA.0000000000000318.;https://journals.lww.com/jcma/Abstract/latest/Potential_therapeutic_agents_against_COVID_19_.99760.aspx 1474;The epidemiology, diagnosis and treatment of COVID-19.;English;Review;COVID-19, SARS-CoV-2,Chloroquine, Remdesivir, Pandemic, Clinical trials;32234468;28/03/2020;Zhai P. et al.;China;138;Int J Antimicrob Agents.;Int J Antimicrob Agents. 2020 Mar 28:105955.;Chloroquine/Remdesivir;10.1016/j.ijantimicag.2020.105955;https://www.sciencedirect.com/science/article/pii/S0924857920301059?via%3Dihub 1477;Race to find COVID-19 treatments accelerates.;English;News;COVID-19, SARS-CoV-2,Chloroquine;32217705;27/03/2020;Kupferschmidt K. and Cohen J.;USA;3;Science.;"Science. 2020 Mar 27;367(6485):1412-1413.";Chloroquine/Remdesivir;10.1126/science.367.6485.1412.;https://science.sciencemag.org/content/367/6485/1412.long 1479;Controversial treatments: An updated understanding of the coronavirus disease 2019.;English;Review;COVID-19, SARS-CoV-2,Chloroquine;32219882;26/03/2020;Zhang C. et al.;China;25;J Med Virol.;J Med Virol. 2020 Mar 26.;Chloroquine/Remdesivir;10.1002/jmv.25788.;https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25788 1484;Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy.;English;Research Article;COVID-19, SARS-CoV-2,Chloroquine, baricitinib, sepsis, respiratory distress syndrome, Pregnancy;32217113;23/03/2020;Dashraath P. et al.;Singapore;30;Am J Obstet Gynecol.;Am J Obstet Gynecol. 2020 Mar 23. pii: S0002-9378(20)30343-4.;Chloroquine/Remdesivir;10.1016/j.ajog.2020.03.021.;https://www.ajog.org/article/S0002-9378(20)30343-4/pdf 1488;Clinical trials on drug repositioning for COVID-19 treatment.;English;Research Article;COVID-19, SARS-CoV-2,Chloroquine, pandemics, pneumonia, Drug repositioning;32256547;20/03/2020;Rosa SGV and Santos WC;Brazil;153;Rev Panam Salud Publica.;"Rev Panam Salud Publica. 2020 Mar 20;44:e40.";Chloroquine/Remdesivir;10.26633/RPSP.2020.40;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105280/ 1493;Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.;English;View;Coronavirus, COVID-19, cytokine storm, multiorgan failure, expanded umbilical cord mesenchymal stem cells, Chloroquine;32214286;23/03/2020;Atluri S. et al.;USA;158;Pain Physician.;"Pain Physician. 2020 Mar;23(2):E71-E83.";Chloroquine/Remdesivir;NA;https://www.painphysicianjournal.com/linkout?issn=1533-3159&vol=23&page=E71 1501;To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.;English;CORRESPONDENCE;COVID-19, SARS-CoV-2,Chloroquine;32241791;02/04/2020;Spinelli FR;Italy;162;Ann Rheum Dis.;Ann Rheum Dis. 2020 Apr 2. pii: annrheumdis-2020-217367.;Chloroquine/Remdesivir;10.1136/annrheumdis-2020-217367.;https://ard.bmj.com/content/early/2020/03/26/annrheumdis-2020-217367.long 1511;"Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.";English;Review;COVID-19, Epidemiology, Hydroxychloroquine, Hypothesis, Immunity, Pathogenesis, Vaccines, Vitamin D;32277367;10/04/2020;Misra DP et al.;India;141;Clin Rheumatol.;Clin Rheumatol. 2020 Apr 10.;Chloroquine/Hydroxychloroquine/Remdesivir/Lopinavir-Ritonavir;10.1007/s10067-020-05073-9.;https://link.springer.com/article/10.1007/s10067-020-05073-9 1532;Cardiovascular Considerations in Treating Patients with Coronavirus (COVID-19).;English;Communication;COVID-19, Cardiovascular diseases;32282502;02/04/2020;Dixon DL. et al.;USA/Italy;174;J Cardiovasc Pharmacol. ;J Cardiovasc Pharmacol. 2020 Apr 2.;Chloroquine/Hydroxychloroquine /Remdesivir;10.1097/FJC.0000000000000836.;https://journals.lww.com/cardiovascularpharm/Abstract/9000/Cardiovascular_Considerations_in_Treating_Patients.98412.aspx 1533;COVID-19: A Brief Overview of the Discovery Clinical Trial.;English;Communication;COVID-19, SARS-CoV-2, chloroquine, hydroxychloroquine, lopinavir/ritonavir, remdesivir, repurposing;32290348;10/04/2020;Vanden Eynde JJ;Belgium;175;Pharmaceuticals (Basel).;"Pharmaceuticals (Basel). 2020 Apr 10;13(4). pii: E65.";Chloroquine/Remdesivir;10.3390/ph13040065.;https://www.mdpi.com/1424-8247/13/4/65 1535;Antiviral treatment of COVID-19.;English;Review;Covid-19, Sars-CoV-2, chloroquine, antiviral;32293834;15/04/2020;Simsek Yavuz S. and Unal S.;Turkey;177;Turk J Med Sci.;Turk J Med Sci. 2020 Apr 15.;Chloroquine/hydroxychloroquine/Remdesivir/Lopinavir-Ritonavir/favipiravir/Nitazoxanide ;10.3906/sag-2004-145;http://online.journals.tubitak.gov.tr/openInPressDocument.htm?fileID=1291231&no=223892&fileType=Report%20Document 1539;SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus.;English;Perspective;COVID-19, Coronavirus, SARS CoV-2, antiviral drugs, favirapivir, hydroxychloroquine, lopinavir, remdesivir, ritonavir.;32297571;16/04/2020;Costanzo M. et al.;Italy;179;Curr Med Chem.;Curr Med Chem. 2020 Apr 16.;Chloroquine/Hydroxychloroquine/Lopinavir-Ritonavir/Darunavir/Umifenovir/Remdesivir/Favipiravir;10.2174/0929867327666200416131117.;http://www.eurekaselect.com/602/journal/current-medicinal-chemistry 1551;Emerging Therapeutic Strategies for COVID-19 patients.;English;Review;2019-nCoV, COVID-19, Coronavirus, SARS-COV-2, abidol, chloroquine phosphate, lopinavir/ ritonavir, plasma, remdesivir;32309622;20/04/2020;Zhu S. et al.;China/USA;184;Discoveries (Craiova).;"Discoveries (Craiova). 2020 Mar 12;8(1):e105.";Chloroquine/Lopinavir-Ritonavir/Remdesivir/Abidol;10.15190/d.2020.2.;https://discoveriesjournals.org/discoveries/D.2020.01.FR-SZ.DOI 1592;[Medication and comedication in COVID-19 patients].;Dutch;Review;COVID-19, Chloroquine;32324352;25/03/2020;Lenkens M. et al.;The Netherlands;197;Ned Tijdschr Geneeskd.;"Ned Tijdschr Geneeskd. 2020 Mar 25;164. pii: D4995.";Chloroquine/Remdesivir/Lopinavir-Ritonavir;NA;https://www.ntvg.nl/system/files/publications/d4995.pdf 1603;Andrographolide As a Potential Inhibitor of SARS-CoV-2 Main Protease: An In Silico Approach.;English;Research Article;Andrographolide, In Silico studies, Plant Compound, SARS-CoV-2, SWISS-Bioinformatics;32329419;24/04/2020;Enmozhi SK. et al.;India;205;J Biomol Struct Dyn.;J Biomol Struct Dyn. 2020 Apr 24:1-10. ;Chloroquine/Remdesivir;10.1080/07391102.2020.1760136;https://www.tandfonline.com/doi/full/10.1080/07391102.2020.1760136 1607;Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19.;English;Review;COVID-19, RNA-dependent, RNA polymerase, SARS-CoV-2, chloroquine, remdesivir, spike glycoproteins;32326602;15/04/2020;Huang J. et al.;USA/China;14;J Clin Med. 2020 Apr ;"J Clin Med. 2020 Apr 15;9(4). pii: E1131";Chloroquine/Remdesivir;10.3390/jcm9041131.;https://www.mdpi.com/2077-0383/9/4/1131 1612;Treatment options for COVID-19: The reality and challenges.;English;Review;Angiotensin converting enzyme inhibitors, Coronavirus disease 2019 (COVID-19), Hydroxychloroquine, Non-steroidal anti-inflammatory drugs, Remdesivir, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2);32307245;21/04/2020;Jean SS. et al.;Taiwan;172;J Microbiol Immunol Infect.;J Microbiol Immunol Infect. 2020 Apr 4. pii: S1684-1182(20)30094-3.;Chloroquine/Hydroxychloroquine/Azithromycin/Remdesivir/Lopinavir-Ritonavir;10.1016/j.jmii.2020.03.034.;https://www.sciencedirect.com/science/article/pii/S1684118220300943?via%3Dihub 1618;Some drugs for COVID-19.;English;Review;ACE inhibitors, ARBs, Actemra, Advil, HIV, Kaletra, Kevzara, Motrin, NSAIDs, Plaquenil, Tylenol, acetaminophen, adverse effects, angiotensin receptor blockers, antiretrovirals, azithromycin, chloroquine, coronavirus, corticosteroids, hydroxychloroquine, ibuprofen, lopinavir, oseltamivir, remdesivir,;32324177;07/04/2020;[No authors listed];NA;208;Med Lett Drugs Ther.;"Med Lett Drugs Ther. 2020 Apr 6;62(1595):49-50.";Chloroquine/Hydroxychloroquine/Azithromycin/Remdesivir;NA;https://secure.medicalletter.org/w1595a 1620;Chloroquine hype is derailing the search for coronavirus treatments.;English;News;COVID-19, Chloroquine, coronavirus treatment;32332911;24/04/2020;Ledford H.;USA;2;Nature;Nature, 2020;Chloroquine/Remdesivir;10.1038/d41586-020-01165-3;https://www.nature.com/articles/d41586-020-01165-3 1621;Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2.;English;Research Article;COVID-19, SARS-CoV-2, children;32318706;22/04/2020;Chiotos K. et al.;USA;214;J Pediatric Infect Dis Soc.;J Pediatric Infect Dis Soc. 2020 Apr 22. pii: piaa045. ;Remdesivir;10.1093/jpids/piaa045.;https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piaa045/5823622 1622;Is Low Alveolar Type II Cell SOD3 in the Lungs of Elderly Linked to the Observed Severity of COVID-19?;English;Research Article;COVID-19, ;32323565;23/04/2020;Abouhashem AS. et al.;Egypt;215;Antioxid Redox Signal.;Antioxid Redox Signal. 2020 Apr 23.;Remdesivir;10.1089/ars.2020.8111.;https://www.liebertpub.com/doi/10.1089/ars.2020.8111 1623;Remdesivir in covid-19.;English;EDITORIAL;COVID-19, Remdesivir;32321732;22/04/2020;Ferner RE. and Aronson JK.;UK;10;BMJ.;"BMJ. 2020 Apr 22;369:m1610.";Remdesivir;10.1136/bmj.m1610.;https://www.bmj.com/content/369/bmj.m1610 1624;"Current pharmacological treatments for COVID-19: whatés next?";English;Review;"COVID-19; anti-inflammatory agents; antivirals; clinical practice; clinical research; immuno-modulatory agents; literature review; pharmacological treatments";32329520;24/04/2020;Scavone C. et al.;The Netherlands/France/Italy/Japan/USA;216;Br J Pharmacol.;Br J Pharmacol. 2020 Apr 24.;Remdesivir/Lopinavir-Ritonavir;10.1111/bph.15072.;https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bph.15072 1625;Compassionate Use of Remdesivir for Patients with Severe Covid-19.;English;Research Article;COVID-19, Remdesivir;32275812;10/04/2020;Grein J. et al.;The Netherlands/France/Italy/Japan/USA;1;N Engl J Med.;N Engl J Med. 2020 Apr 10.;Remdesivir;10.1056/NEJMoa2007016.;https://www.nejm.org/doi/10.1056/NEJMoa2007016 1626;An alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections.;English;Review;COVID-19, SARS-CoV-2;32329879;24/04/2020;Ahmad A. et al.;Saudi Arabia;217;Eur Rev Med Pharmacol Sci.;"Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):4030-4034.";Hydroxychloroquine/Tocilizumab/Lopinavir-ritonavir/Remdesivir;10.26355/eurrev_202004_20873;https://www.europeanreview.org/article/20873 1627;Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.;English;Review;COVID-19, SARS-CoV-2;32282022;13/04/2020;Sanders JM. et al.;USA;4;JAMA.;JAMA. 2020 Apr 13.;Remdesivir;10.1001/jama.2020.6019.;https://jamanetwork.com/journals/jama/fullarticle/2764727 1628;Efficacy of remdesivir in a rhesus macaque model of MERS-CoV infection.;English;Research Highlight;COVID-19, MERS-CoV, Remdesivir;32284571;13/04/2020;Le Bras A.;UK;218;Lab Anim (NY).;"Lab Anim (NY). 2020 May;49(5):150.";Remdesivir;10.1038/s41684-020-0537-x.;https://www.nature.com/articles/s41684-020-0537-x 1629;Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.;English;Research Article;COVID-19, RNA polymerase, drug action, drug development, drug discovery, plus-stranded RNA virus;32284326;13/04/2020;Gordon CJ. et al.;Canada;219;J Biol Chem.;J Biol Chem. 2020 Apr 13. pii: jbc.RA120.013679.;Remdesivir;10.1074/jbc.RA120.013679.;https://www.jbc.org/content/early/2020/04/15/jbc.RA120.013679 1630;A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease.;English;Research Article;"COVID-19; Approved drugs; Coronavirus; Medications; Molecular docking; SARS-CoV-2";32294562;12/04/2020;Hall DC Jr. and Ji HF.;USA;212;Travel Med Infect Dis.;Travel Med Infect Dis. 2020 Apr 12:101646.;Zanamivir/Indinavir/Saquinavir/Remdesivir;10.1016/j.tmaid.2020.101646;https://www.sciencedirect.com/science/article/pii/S1477893920301150?via%3Dihub 1631;Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies.;English;EDITORIAL;"COVID-19; Host factor; Influenza virus; SARS-CoV-2; Therapeutics; drug discovery";32292909;30/03/2020;Liao J. et al.;USA;186;Med Drug Discov.;Med Drug Discov. 2020 Apr 13:100037.;Chloroquine/Hydroxychloroquine/Remdesivir;10.1016/j.medidd.2020.100037;https://www.sciencedirect.com/science/article/pii/S2590098620300245?via%3Dihub 1632;Importance of inclusion of pregnant and breastfeeding women in COVID-19 therapeutic trials.;English;View;"COVID-19; pregnancy; treatment; trial";32296817;15/04/2020;LaCourse SM. et al.;USA;5;Clin Infect Dis.;Clin Infect Dis. 2020 Apr 15. pii: ciaa444.;Remdesivir;10.1093/cid/ciaa444.;https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa444/5820683 1633;Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.;English;Review;"Corona virus disease 2019; Phase III clinical trial; Remdesivir; Severe acute respiratory syndrome coronavirus 2";32247927;02/04/2020;Cao YC. et al.;China;212;Travel Med Infect Dis.;Travel Med Infect Dis. 2020 Apr 2:101647.;Remdesivir;10.1016/j.tmaid.2020.101647.;https://www.sciencedirect.com/science/article/pii/S1477893920301162?via%3Dihub 1634;Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses.;English;Review;"COVID-19; Compassionate use; Coronavirus; GS-5734; Remdesivir; SARS-CoV-2";32258351;27/03/2020;Amirian ES. and Levy JK.;USA;176;One Health.;"One Health. 2020 Mar 27;9:100128.";Remdesivir ;10.1016/j.onehlt.2020.100128.;https://www.sciencedirect.com/science/article/pii/S2352771420300380?via%3Dihub 1635;An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.;English;Research Article;"COVID-19; SARS-CoV-2";32253226;06/04/2020;Sheahan TP. et al.;USA;224;Sci Transl Med.;Sci Transl Med. 2020 Apr 6. pii: eabb5883.;Remdesivir;10.1126/scitranslmed.abb5883.;https://stm.sciencemag.org/content/early/2020/04/03/scitranslmed.abb5883.short 1636;Halting coronavirus polymerase.;English;Research Article;COVID-19, RNA-dependent RNA polymerases, Remdesivir ;32277065;10/04/2020;Kirchdoerfer RN;USA;219;J Biol Chem.;"J Biol Chem. 2020 Apr 10;295(15):4780-4781.";Remdesivir;10.1074/jbc.H120.013397.;https://www.jbc.org/content/295/15/4780.long 1637;Structure of the RNA-dependent RNA polymerase from COVID-19 virus.;English;Report;COVID-19;32277040;10/04/2020;Gao Y. et al.;China;3;Science.;Science. 2020 Apr 10. pii: eabb7498.;Remdesivir;10.1126/science.abb7498.;https://science.sciencemag.org/content/early/2020/04/09/science.abb7498.long 1638;Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.;English;Research Article;"COVID-19; Coronavirus; Exonuclease; Mutation; Nucleotide analogue; RNA-Dependent RNA polymerase; Remdesivir; Resistance";32283108;10/04/2020;Shannon A. et al.;France;50;Antiviral Res.;"Antiviral Res. 2020 Apr 10;178:104793.";Remdesivir;10.1016/j.antiviral.2020.104793.;https://www.sciencedirect.com/science/article/pii/S0166354220302072?via%3Dihub 1639;Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model.;English;Research Article;"Atazanavir; COVID-19; Coronavirus; Deep learning; Drug repurposing; MT-DTI; SARS-CoV-2";32280433;30/03/2020;Beck BR. et al.;Republic of Korea/USA;225;Comput Struct Biotechnol J.;"Comput Struct Biotechnol J. 2020 Mar 30;18:784-790.";Remdesivir/Lopinavir-Ritonavir/Atazanavir;10.1016/j.csbj.2020.03.025.;https://www.sciencedirect.com/science/article/pii/S2001037020300490?via%3Dihub 1640;Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study.;English;Research Article;"COVID-19; Drug repurposing; Molecular docking; RdRp; SARS-CoV-2; Structural bioinformatics";32222463;25/03/2020;Elfiky AA;Egypt;222;Life Sci.;"Life Sci. 2020 Mar 25;253:117592.";Ribavirin/Remdesivir/Sofosbuvir/ Galidesivir/Tenofovir;10.1016/j.lfs.2020.117592.;https://www.sciencedirect.com/science/article/pii/S0024320520303404?via%3Dihub 1641;Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach.;English;Research Article;"3CLpro; MD simulation; SARS-CoV-2; corona virus; drug repurposing; remdesivir; virtual screening";32238094;02/04/2020;Khan SA. et al.;Pakistan;205;J Biomol Struct Dyn.;J Biomol Struct Dyn. 2020 Apr 13:1-10.;Remdesivir/Saquinavir/Darunavir;10.1080/07391102.2020.1751298.;https://www.tandfonline.com/doi/full/10.1080/07391102.2020.1751298 1642;[Remdesivir, the antiviral hope against SARS-CoV-2].;Spanish;Review;"SARS-CoV-2; remdesivir; treatment";32239125;01/04/2020;Reina J.;Spain;231;Rev Esp Quimioter.;Rev Esp Quimioter. 2020 Apr 1. pii: reina01apr2020.;Remdesivir;10.37201/req/028.2020;https://seq.es/abstract/rev-esp-quimioter-2020-april-1-2/ 1643;COVID-19 in Solid Organ Transplant Recipients: Initial Report from the US Epicenter.;English;Research Article;COVID-19, SARS‐CoV-2;32330343;24/04/2020;Pereira MR. et al.;USA;34;Am J Transplant.;Am J Transplant. 2020 Apr 24.;Hydroxychloroquine/Remdesivir/Tocilizumab/Azithromycin/Tocilizumab;10.1111/ajt.15941.;https://onlinelibrary.wiley.com/doi/abs/10.1111/ajt.15941 1644;[Remdesivir for patients with severe COVID-19].;German;Review;"COVID-19; Remdesivir";32333086;24/04/2020;Augustin M. et al.;Germany;223;Internist (Berl).;Internist (Berl). 2020 Apr 24.;Remdesivir;10.1007/s00108-020-00800-5.;https://link.springer.com/article/10.1007%2Fs00108-020-00800-5 1645;COVID-2019: update on epidemiology, disease spread and management.;English;Review;COVID-19;32297723;16/04/2020;Sahu KK. et al.;USA;140;Monaldi Arch Chest Dis.;"Monaldi Arch Chest Dis. 2020 Apr 16;90(1). ";Remdesivir;10.4081/monaldi.2020.1292.;https://monaldi-archives.org/index.php/macd/article/view/1292 1646;Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.;English;Research Article;"COVID-19; Emetine; Homoharringtonine; Lopinavir; Remdesivir; Ritonavir";32282982;03/04/2020;Choy KT. et al.;China;50;Antiviral Res.;"Antiviral Res. 2020 Apr 3;178:104786.";Remdesivir/Ritonavir/Lopinavir;10.1016/j.antiviral.2020.104786.;https://onlinelibrary.wiley.com/doi/abs/10.1111/ajt.15915 1647;Delayed Initiation of Remdesivir in a COVID-19 Positive Patient.;English;Case Report;"COVID-19; SARS-CoV-2; coronavirus; pneumonia; remdesivir; viral pneumonia";32281114;13/04/2020;Hillaker E. et al.;USA;226;Pharmacotherapy.;Pharmacotherapy. 2020 Apr 13.;Remdesivir;10.1002/phar.2403.;https://accpjournals.onlinelibrary.wiley.com/doi/abs/10.1002/phar.2403 1648;Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options.;English;Review;"COVID-19; SARS-CoV-2; hydroxychloroquine; lopinavir/ritonavir; remdesivir";32284951;23/03/2020;McCreary EK. and Pogue JM.;USA;227;Open Forum Infect Dis.;"Open Forum Infect Dis. 2020 Mar 23;7(4):ofaa105";Hydroxychloroquine/Remdesivir/lopinavir/ritonavir;10.1093/ofid/ofaa105.;https://academic.oup.com/ofid/article/7/4/ofaa105/5811022 1649;Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.;English;Research Article;"3CLpro, 3-chymotrypsin-like protease; Drug repurposing; E, envelope; Homology modeling; M, membrane protein; Molecular docking; N, nucleocapsid protein; Nsp, non-structure protein; ORF, open reading frame; PDB, protein data bank; RdRp, RNA-dependence RNA polymerase; Remdesivir; S, Spike; SARS-CoV-2;";32292689;27/02/2020;Wu C. et al.;China;230;Acta Pharm Sin B.;Acta Pharm Sin B. 2020 Feb 27.;Chloroquine/Remdesivir;10.1016/j.apsb.2020.02.008.;https://linkinghub.elsevier.com/retrieve/pii/S2211-3835(20)30299-9 1650;Vademecum for the treatment of people with COVID-19. Edition 2.0, 13 March 2020.;English;Review;"COVID-19; treatment";32275256;13/03/2020;Lombardy Section Italian Society Infectious And Tropical Diseases;Italy;232;Infez Med.;"Infez Med. 2020 Ahead of print Jun 1;28(2):143-152.";Remdesivir;NA;https://www.infezmed.it/index.php/article?Anno=2020&numero=2&ArticoloDaVisualizzare=Vol_28_2_2020_143 1651;Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING.;English;Research Article;"Dyslipidemia; Inflammation; NAFLD; Remdesivir; STING";32223926;27/03/2020;China;Li YN. and Su Y.;54;Biochem Biophys Res Commun.;Biochem Biophys Res Commun. 2020 Mar 26. pii: S0006-291X(20)30513-1.;Remdesivir;10.1016/j.bbrc.2020.03.034.;https://www.sciencedirect.com/science/article/pii/S0006291X20305131?via%3Dihub 1652;The race against COVID-19.;English;EDITORIAL;"COVID-19; treatment";32303704;17/04/2020;[No authors listed];NA;233;Nat Nanotechnol.;"Nat Nanotechnol. 2020 Apr;15(4):239-240.";Chloroquine/Remdesivir;10.1038/s41565-020-0680-y.;https://www.nature.com/articles/s41565-020-0680-y 1670;Flooded by the torrent: the COVID-19 drug pipeline.;English;COMMENT;"COVID-19; Treatments";32305088;18/04/2020;Mullard A.;UK;11;Lancet.;"Lancet. 2020 Apr 18;395(10232):1245-1246. ";Chloroquine/Hydroxychloroquine/Lopinavir-Ritonavir/Remdesivir;10.1016/S0140-6736(20)30894-1.;https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)30894-1.pdf 1672;"Pharmacotherapy in COVID-19; A narrative review for emergency providers.";English;Review;"COVID 19; Favipiravir; Hydroxychloroquine; Remdesivir; SARS-CoV-2";32336586;15/04/2020;Mehta N. et al.;USA;288;Am J Emerg Med.;Am J Emerg Med. 2020 Apr 15. pii: S0735-6757(20)30263-1.;Chloroquine/Hydroxychloroquine/Remdesivir /Favipiravir;10.1016/j.ajem.2020.04.035.;https://www.ajemjournal.com/article/S0735-6757(20)30263-1/pdf 1676;SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silico perspective.;English;Research Article;"COVID-19; RdRp; SARS-CoV-2; drug repurposing; molecular docking; molecular dynamics simulation";32338164;06/05/2020;Elfiky AA;Egypt;205;J Biomol Struct Dyn.;J Biomol Struct Dyn. 2020 May 6:1-9.;Sofosbuvir/Ribavirin/Galidesivir/Remdesivir/Favipiravir/Cefuroxime/Tenofovir/Hydroxychloroquine;10.1080/07391102.2020.1761882.;https://www.tandfonline.com/doi/full/10.1080/07391102.2020.1761882 1694;Medication for COVID-19-an Overview of Approaches Currently Under Study.;English;Review;COVID-19;32343658;27/03/2020;Stahlmann R. and Lode H.;Germany;278;Dtsch Arztebl Int.;"Dtsch Arztebl Int. 2020 Mar 27;117(13):213-219.";Chloroquine/Nitazoxanide/Remdesivir;10.3238/arztebl.2020.0213.;https://www.aerzteblatt.de/int/archive/article/213208 1699;Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2.;English;Review;"2019-ncov; acei; arb; chloroquine; corona virus; corticosteroids; covid-19; novel coronavirus; remdesivir; sars-cov-2";32337113;24/03/2020;Valencia DN.;USA;147;Cureus.;"Cureus. 2020 Mar 24;12(3):e7386.";Chloroquine/Remdesivir;10.7759/cureus.7386.;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179986/ 1705;Candidate drugs against SARS-CoV-2 and COVID-19.;English;Review;"COVID-19; SARS-CoV-2; arbidol; camostat; chloroquine; drugs; favipiravir; lopinavir; phytochemicals; remdesivir; ritonavir";32360480;29/04/2020;McKee DL. et al.;USA/Germany;273;Pharmacol Res.;Pharmacol Res. 2020 Apr 29:104859.;Chloroquine/Hydroxychloroquine/Remdesivir/Favipiravir/Arbidol/Lopinavir-Ritonavir;10.1016/j.phrs.2020.104859.;https://www.sciencedirect.com/science/article/pii/S1043661820311671?via%3Dihub 1719;COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.;English;Research Article;"ACE2; Acute coronary syndrome; COVID-19; Cardiac; Endothelium; Microvascular; Myocardial infarction; Myocarditis; Vascular; Virus";32352535;30/04/2020;Guzik TJ. et al.;UK/Poland/UK/Italy/China/USA;265;Cardiovasc Res.;Cardiovasc Res. 2020 Apr 30. pii: cvaa106.;Chloroquine/Hydroxychloroquine/Remdesivir/Tocilizumab/Lopinavir-ritonavir/Ribavirin;10.1093/cvr/cvaa106.;https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvaa106/5826160 1720;Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action.;English;COMMENT;"Adverse effects; China; Chloroquine; Coronavirus infectious disease-2019 (COVID-19); Drugs; MERS; SARS; Therapy";32350686;29/04/2020;Khan Z. et al.;Turkey/Pakistan;263;Adv Ther.;Adv Ther. 2020 Apr 29.;Chloroquine/Hydroxychloroquine/Remdesivir/Lopinavir-ritonavir;10.1007/s12325-020-01351-9.;https://link.springer.com/article/10.1007/s12325-020-01351-9 1723;Cutaneous Side-Effects of the Potential Covid-19 Drugs.;English;Review;"COVID-19; dermatology; side-effects; skin";32358890;01/05/2020;Tursen U. et al.;Turkey;87;Dermatol Ther.;Dermatol Ther. 2020 May 1:e13476.;Chloroquine/Hydroxychloroquine/Remdesivir/Inteferon-beta/Lopinavir-ritonavir;10.1111/dth.13476;https://onlinelibrary.wiley.com/doi/abs/10.1111/dth.13476 1724;Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines.;English;Review;"Adjunctive treatment; COVID-19; Chloroquine; Convalescent plasma; Corticosteroids; Lopinavir-ritonavir; Remdesivir; Umifenovir";32370766;05/05/2020;Xu X. et al.;Singapore;261;Mil Med Res.;"Mil Med Res. 2020 May 5;7(1):22.";Chloroquine/Hydroxychloroquine/Remdesivir/Umifenovir/Lopinavir-ritonavir/Convalescent plasma/Cortico;10.1186/s40779-020-00251-x.;https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-020-00251-x 1728;Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus.;English;Research Article;"Autodock tool; Coronavirus; antiviral drugs; chloroquine; pkCSM tool";32375574;07/05/2020;Adeoye AO. et al.;Nigeria;205;J Biomol Struct Dyn.;J Biomol Struct Dyn. 2020 May 7:1-14;Chloroquine/Hydroxychloroquine/Remdesivir;10.1080/07391102.2020.1765876.;https://www.tandfonline.com/doi/full/10.1080/07391102.2020.1765876 1731;COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus.;English;Review;"COVID-19; Chloroquine; MERS; Morbidity; Rendesivir.; SARS-CoV-2";32377559;26/04/2020;Jan H. et al.;Pakistan;184;Discoveries (Craiova).;"Discoveries (Craiova). 2020 Apr 26;8(2):e108.";Chloroquine/Hydroxychloroquine/Remdesivir;10.15190/d.2020.5.;https://discoveriesjournals.org/discoveries/D.2020.02.RA-Hasnain.DOI 1733;Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19.;English;Review;"COVID-19; HIV; antiviral drugs; coronaviruses; extracellular vesicles; protease inhibitors";32357553;26/04/2020;Kumar S. et al.;USA;255;Viruses.;"Viruses. 2020 Apr 26;12(5). pii: E486.";Chloroquine/Hydroxychloroquine/Remdesivir/Lopinavir-Ritonavir;10.3390/v12050486.;https://www.mdpi.com/1999-4915/12/5/486 1757;Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.;English;Research Article;"COVID-19; Remdesivir";NA;29/04/2020;Wang Y. et al.;China;11;Lancet;Lancet, 2020;Remdesivir;10.1016/S0140-6736(20)31022-9;https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931022-9 1760;Treatment of SARS-CoV-2: How far have we reached?;English;Review;"SARS-CoV-2; antiviral; clinical trial; corona virus; pandemic";32336723;06/05/2020;Ahsan W. et al.;Saudi Arabia;78;Drug Discov Ther.;"Drug Discov Ther. 2020 May 6;14(2):67-72.";Chloroquine/Hydroxychloroquine/Remdesivir;10.5582/ddt.2020.03008.;https://www.jstage.jst.go.jp/article/ddt/14/2/14_2020.03008/_article 1761;Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.;English;Report;SARS-CoV-2, COVID-19, Remdesivir;32358203;01/05/2020;Yin W. et al.;China;3;Science.;Science. 2020 May 1. pii: eabc1560.;Remdesivir;10.1126/science.abc1560.;https://science.sciencemag.org/content/early/2020/04/30/science.abc1560.long 1762;Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease.;English;Research Article;"SARS-CoV-2;COVID-19;pharmacokinetics";32361744;03/05/2020;Avataneo V. et al.;Italy/UK/Uganda;161;J Antimicrob Chemother.;J Antimicrob Chemother. 2020 May 3. pii: dkaa152.;Remdesivir;10.1093/jac/dkaa152.;https://academic.oup.com/jac/advance-article/doi/10.1093/jac/dkaa152/5828362 1763;Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock.;English;Research Article;"COVID-19; Coronavirus; Molecular docking; Protein homology modelling; SARS-CoV-2";32363219;02/05/2020;Mothay D. and Ramesh KV.;India;289;Virusdisease.;Virusdisease. 2020 May 2:1-6. ;Remdesivir/Nelfinavir/Lopinavir/Ritonavir/Alpha-ketoamide;10.1007/s13337-020-00585-z;https://link.springer.com/article/10.1007%2Fs13337-020-00585-z 1764;Rapid review for the anti-coronavirus effect of remdesivir.;English;Review;"COVID-19; SARS-CoV-2; effect; remdesivir; safety";32378648;06/05/2020;Li Z. et al.;China/Canada;78;Drug Discov Ther.;"Drug Discov Ther. 2020;14(2):73-76. ";Remdesivir;10.5582/ddt.2020.01015.;https://www.jstage.jst.go.jp/article/ddt/14/2/14_2020.01015/_article 1765;An overview of coronaviruses including the SARS-2 coronavirus - Molecular biology, epidemiology and clinical implications.;English;Review;"Betacoronavirues; COVID-19; Coronaviruses; SARS-CoV-1; SARS-CoV-2; Wuhan";32363221;09/04/2020;Kaul D.;India;290;Curr Med Res Pract.;Curr Med Res Pract. 2020 Apr 9. ;Remdesivir;10.1016/j.cmrp.2020.04.001.;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194867/ 1766;Using Integrated Computational Approaches to Identify Safe and Rapid Treatment for SARS -CoV- 2.;English;Research Article;"MD simulation; Mpro; PCA; SARS-CoV-2; covalent docking; drug repurposing";32364041;15/05/2020;Al-Khafaji K. et al.;Turkey/Iraq;205;J Biomol Struct Dyn.;J Biomol Struct Dyn. 2020 May 15:1-9.;Saquinavir/Ritonavir/Remdesivir/Delavirdine/Cefuroxime axetil/Oseltamivir and prevacid;10.1080/07391102.2020.1764392.;https://www.tandfonline.com/doi/full/10.1080/07391102.2020.1764392 1773;Novel coronavirus 2019 (COVID-19): A case report and review of treatments.;English;Case Reports;"COVID-19;SARS-CoV-2";32384516;10/05/2020;Douedi S. and Miskoff J.;USA;291;Medicine (Baltimore).;"Medicine (Baltimore). 2020 May;99(19):e20207.";Hydroxychloroquine/Remdesivir;10.1097/MD.0000000000020207.;https://journals.lww.com/md-journal/FullText/2020/05080/Novel_coronavirus_2019__COVID_19___A_case_report.93.aspx 1774;Five reasons why data on compassionate use of remdesivir deserved publication (and are worth reading).;English;View;"COVID-19; Remdesivir";32364611;04/05/2020;Lapadula G.;Italy;196;Swiss Med Wkly.;"Swiss Med Wkly. 2020 May 4;150:w20265.";Remdesivir;10.4414/smw.2020.20265.;https://smw.ch/article/doi/smw.2020.20265 1775;Covid-19: Remdesivir is helpful but not a wonder drug, say researchers.;English;News;"Covid-19; Remdesivir";32357949;01/05/2020;Mahase E.;UK;10;BMJ.;"BMJ. 2020 May 1;369:m1798.";Remdesivir;10.1136/bmj.m1798.;https://www.bmj.com/content/369/bmj.m1798.long 1776;Hopes rise for coronavirus drug remdesivir.;English;News;"Infection; Medical research; SARS-CoV-2; Virology";32350436;29/04/2020;Ledford H.;UK;2;Nature.;Nature. 2020 Apr 29. ;Remdesivir;10.1038/d41586-020-01295-8.;https://www.nature.com/articles/d41586-020-01295-8 1777;SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?;English;Review;"Baricitinib; COVID-19; Corona virus cycle; Coronavirus; Coronaviruses; Drugs; Hydroxychloroquine; Remdesivir; SARS-CoV; SARS-CoV-2; Strategies; Targets; Therapies; Tocilizumab";32334088;22/04/2020;Magro G.;Italy;212;Travel Med Infect Dis.;Travel Med Infect Dis. 2020 Apr 22:101685. ;Hydroxychloroquine/Remdesivir/Tocilizumab/Baricitinib;10.1016/j.tmaid.2020.101685.;https://www.sciencedirect.com/science/article/pii/S1477893920301538?via%3Dihub 1778;Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study.;English;Research Article;"COVID-19; SARs-CoV2; coronavirus; pregnancy";32391519;08/05/2020;Pierce-Williams RAM. et al.;USA;293;Am J Obstet Gynecol MFM.;Am J Obstet Gynecol MFM. 2020 May 8:100134;Remdesivir;10.1016/j.ajogmf.2020.100134.;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205698/ 1779;Computational screening of antagonist against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking.;English;Review;"2019-nCoV; autoDock vina; chloroquine; luteolin; remdesivir; ribavirin";32389723;07/05/2020;Yu R. et al.;China;138;Int J Antimicrob Agents.;Int J Antimicrob Agents. 2020 May 7:106012.;Chloroquine/Remdesivir/Ribavirin/Luteolin;10.1016/j.ijantimicag.2020.106012.;https://www.sciencedirect.com/science/article/pii/S0924857920301709?via%3Dihub 1780;[Chloroquine as a possible treatment for COVID-19].;Dutch;COMMENT;COVID-19;32391999;11/03/2020;Coumou J. and de Vries PJ.;The Netherlands;197;Ned Tijdschr Geneeskd.;"Ned Tijdschr Geneeskd. 2020 Mar 11;164. pii: D4936.";Chloroquine/Lopinavir-Ritonavir/Remdesivir ;NA;https://www.ntvg.nl/artikelen/chloroquine-als-mogelijke-behandeling-van-covid-19 1781;A global treatments for coronaviruses including COVID-19.;English;Review;"COVID-19; antiviral; coronavirus; drug; treatment";32394467;11/05/2020;Yousefi B. et al.;Iran;0;J Cell Physiol.;J Cell Physiol. 2020 May 11.;Lopinavir-Ritonavir/Umifenovir/Remdesivir/Ribavirin/Favipiravir ;10.1002/jcp.29785.;https://onlinelibrary.wiley.com/doi/full/10.1002/jcp.29785 1783;What do we know about remdesivir drug interactions?;English;COMMENT;"SARS-Co-V-2; COVID-19";32402130;13/05/2020;Yang K.;USA;163;Clin Transl Sci. ;Clin Transl Sci. 2020 May 13.;Remdesivir;10.1111/cts.12815.;https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1111/cts.12815 1784;In vitro data of current therapies for SARS-CoV-2.;English;Research Article;"ACE2 receptor.; SARS-CoV-2 (COVID-19); VeroE6 Cells; in vitro studies; therapies; vaccines";32400323;12/05/2020;Anastasiou IA. et al.;Greece;179;Curr Med Chem.;Curr Med Chem. 2020 May 12.;Chloroquine/Hydroxychloroquine/Remdesivir/Nitazoxanide/Teicoplanin/Ivermectin/Lopinavir/Homoharringt;10.2174/0929867327666200513075430.;http://www.eurekaselect.com/181895/article 1785;Development of Remdesivir Repositioning as a Nucleotide Analog Against COVID-19 RNA Dependent RNA Polymerase.;English;Review;"Anti-viral; COVID-19; Corona virus; MERS; Remdesivir; SARS; SARS-CoV-2";32397906;13/05/2020;Nejadi Babadaei MM. et al.;Iran/Qatar/United Arab Emirates/Australia;205;J Biomol Struct Dyn.;J Biomol Struct Dyn. 2020 May 13:1-12.;Remdesivir;10.1080/07391102.2020.1767210.;https://www.tandfonline.com/doi/full/10.1080/07391102.2020.1767210 1786;Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Medical Center in New York City.;English;Research Article;COVID-19;32407719;11/05/2020;Chao JY. et al.;USA;301;J Pediatr.;J Pediatr. 2020 May 11. pii: S0022-3476(20)30580-1. ;Remdesivir ;10.1016/j.jpeds.2020.05.006.;https://www.jpeds.com/article/S0022-3476(20)30580-1/pdf 1787;Minimum costs to manufacture new treatments for COVID-19.;English;EDITORIAL;"COVID-19; SARS-CoV2; access to medicines; drug prices";32405423;30/04/2020;Hill A. et al.;UK/US/Australia;302;J Virus Erad.;"J Virus Erad. 2020 Apr 30;6(2):61-69.";Chloroquine/Hydroxychloroquine/Remdesivir/Favipiravir/Azithromycin/Lopinavir-Ritonavir/Sofosbuvir-Da;NA;http://viruseradication.com/journal-details/Minimum_costs_to_manufacture_new_treatments_for_COVID-19/ 1788;COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics.;English;Review;"COVID-19; SARS-CoV-2; infection; repurposed therapies; vaccine; viruses";32397911;12/05/2020;Amawi H. et al.;Jordan/UK/Australia;303;Ther Deliv.;Ther Deliv. 2020 May 12.;Hydroxychloroquine/Remdesivir/Favipiravir/Tocilizumab/Bevacizumab/Umifenovir;10.4155/tde-2020-0035.;https://www.future-science.com/doi/pdf/10.4155/tde-2020-0035 1789;Remdesivir in the treatment of Coronavirus Disease 2019 (COVID-19): A simplified summary.;English;Review;"Covid-19; Remdesivir; treatment";32396771;12/05/2020;Hendaus MA;Qatar;205;J Biomol Struct Dyn. ;J Biomol Struct Dyn. 2020 May 12:1-10.;Remdesivir;10.1080/07391102.2020.1767691.;https://www.tandfonline.com/doi/full/10.1080/07391102.2020.1767691 1790;An Update on Current Therapeutic Drugs Treating COVID-19.;English;Review;"Anakinra; Azithromycin; COVID-19; Chloroquine; Convalescent plasma; Epoprostenol; Favipiravir; Hydroxychloroquine; Lopinavir; Methylprednisolone; Nitric oxide; Oseltamivir; Remdesivir; SAR-CoV-2; Sarilumab; Sirolimus; Tocilizumab; Traditional Chinese Medicine; Umifenovir; Vitamin C";32395418;11/05/2020;Wu R. et al.;USA;304;Curr Pharmacol Rep.;Curr Pharmacol Rep. 2020 May 11:1-15.;Chloroquine/Hydroxychloroquine/Remdesivir/Lopinavir/Umifenovir/Azithromycin/;10.1007/s40495-020-00216-7.;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211915/ 1792;Successful COVID-19 rescue therapy by extra-corporeal membrane oxygenation (ECMO) for respiratory failure: a case report.;English;Case Reports;"COVID-19; Coronavirus; Extra-corporeal membrane oxygenation;";32395179;08/05/2020;Firstenberg MS. et al.;USA;298;Patient Saf Surg.;"Patient Saf Surg. 2020 May 8;14:20.";Remdesivir;10.1186/s13037-020-00245-7.;https://pssjournal.biomedcentral.com/articles/10.1186/s13037-020-00245-7 1793;Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.;English;Short Communication;"COVID-19; Emetine; Homoharringtonine; Lopinavir; Remdesivir; Ritonavir";32251767;03/04/2020;Choy KT. et al.;China;50;Antiviral Res.;"Antiviral Res. 2020 Apr 3;178:104786.";Remdesivir/Lopinavir/Emetine/Homoharringtonine;10.1016/j.antiviral.2020.104786.;https://www.sciencedirect.com/science/article/pii/S016635422030200X?via%3Dihub 1794;[Potential antiviral therapeutics for 2019 Novel Coronavirus].;Chinese;Research Article;"2019 novel coronavirus; Antiviral therapy; Infection";32164080;12/03/2020;Li H. et al.;China;91;Zhonghua Jie He He Hu Xi Za Zhi.;"Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):170-172";Remdesivir;10.3760/cma.j.issn.1001-0939.2020.03.004.;http://rs.yiigle.com/CN112147202003/1184455.htm 1795;Compassionate Use of Remdesivir in Covid-19. Reply.;English;CORRESPONDENCE;"Remdesivir; Covid-19";32412709;15/05/2020;Grein J. et al.;USA;1;N Engl J Med.;"N Engl J Med. 2020 May 15;382. pii: 10.1056/NEJMc2015312#sa5.";Remdesivir;10.1056/NEJMc2015312.;https://www.nejm.org/doi/10.1056/NEJMc2015312 1796;Compassionate Use of Remdesivir in Covid-19.;English;COMMENT;"Remdesivir; Covid-19";32412708;15/05/2020;Wu J. et al.;China;1;N Engl J Med.;"N Engl J Med. 2020 May 15;382. pii: 10.1056/NEJMc2015312#sa4.";Remdesivir;10.1056/NEJMc2015312.;https://www.nejm.org/doi/10.1056/NEJMc2015312 1797;Compassionate Use of Remdesivir in Covid-19.;English;COMMENT;"Remdesivir; Covid-19";32412706;0000-00-00;Faetkenheuer G. and Lundgren J.;Denmark;1;N Engl J Med.;"N Engl J Med. 2020 May 15;382. pii: 10.1056/NEJMc2015312#sa2";Remdesivir;10.1056/NEJMc2015312.;https://www.nejm.org/doi/10.1056/NEJMc2015312 1798;Compassionate Use of Remdesivir in Covid-19.;English;COMMENT;"Remdesivir;Covid-19";32412705;15/05/2020;Bonovas S. and Piovani D.;Italy;1;N Engl J Med.;"N Engl J Med. 2020 May 15;382. pii: 10.1056/NEJMc2015312#sa1. ";Remdesivir;10.1056/NEJMc2015312.;https://www.nejm.org/doi/10.1056/NEJMc2015312 1799;COVID-19 Comes 40 Years After AIDS - Any Lesson?;English;Review;COVID-19;32412509;14/05/2020;Soriano V. et al.;Spain;297;AIDS Rev.;"AIDS Rev. 2020 May 14;22(2).";Remdesivir/Lopinavir-Ritonavir/Tocilizumab/Hydroxychloroquine;NA;https://www.unboundmedicine.com/medline/citation/32412509/COVID-19_Comes_40_Years_After_AIDS_-_Any_Lesson 1800;Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19.;English;Review;"COVID-19; SARS-CoV-2; antiviral; cytokines; indomethacin; inflammation; novel coronavirus; resveratrol";32412158;15/05/2020;Marinella MA.;USA;296;Int J Clin Pract.;Int J Clin Pract. 2020 May 15:e13535.;Remdesivir/Indomethacin/Resveratrol;10.1111/ijcp.13535.;https://onlinelibrary.wiley.com/doi/abs/10.1111/ijcp.13535 1801;Emerging pharmacotherapies for COVID-19.;English;Review;"COVID-19; Chloroquine; Hydroxychloroquine; Remdesivir";32410772;14/05/2020;Salvi R. and Patankar P.;India;295;Biomed Pharmacother. ;Biomed Pharmacother. 2020 May 14:110267. ;Chloroquine/ Hydroxychloroquine/Remdesivir;10.1016/j.biopha.2020.110267.;https://www.sciencedirect.com/science/article/pii/S0753332220304595?via%3Dihub 1802;Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post_treatment hospitalisation status.;English;Review;"COVID-19; Antivirals ";32409433;11/05/2020;Srinivas P. et al.;USA;294;Cleve Clin J Med.;Cleve Clin J Med. 2020 May 14. ;Remdesivir;10.3949/ccjm.87a.ccc030.;https://www.ccjm.org/content/early/2020/05/12/ccjm.87a.ccc030 1803;Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post_treatment hospitalisation status.;English;Perspective;"COVID-19; Remdesivir; SARS-Cov2";32407959;11/05/2020;Antinori S. et al.;Italy;273;Pharmacol Res.;Pharmacol Res. 2020 May 11:104899.;Remdesivir;10.1016/j.phrs.2020.104899.;https://www.sciencedirect.com/science/article/pii/S104366182031207X?via%3Dihub 1804;Compassionate Use of Remdesivir in Covid-19;English;COMMENT;"Remdesivir;Covid-19";32412707;15/05/2020;Hoffmann C.;Germany;1;N Engl J Med.;"N Engl J Med. 2020 May 15;382. pii: 10.1056/NEJMc2015312#sa3.";Remdesivir;10.1056/NEJMc2015312.;https://www.nejm.org/doi/10.1056/NEJMc2015312